PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
Go back to PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 80.46 +1.48 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.98 | 52 Week High | $35.40 | |||
| Open | $80.00 | 52 Week Low | $4.03 | |||
| Day High | $81.71 | P/E | 8.56 | |||
| Day Low | $79.51 | EPS | $9.40 | |||
| Volume | 1,790,424 | |||||
